Catalyst Wire Dossier Catalyst Wire Dossier

Lenacapavir

lenacapavir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Lenacapavir, covering 2020-12-09 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy [Phase 1]

See pricing